Abstract

The advent of proteomics technology has transformed our understanding of biological membranes. The challenges for studying membrane proteins have inspired the development of many analytical and bioanalytical tools, and the techniques of glycoproteomics have emerged as an effective means to enrich and characterize membrane and plasma-membrane proteomes. This Review summarizes the development of various glycoproteomics techniques to overcome the hurdles formed by the unique structures and behaviors of membrane proteins with a focus on N-glycoproteomics. Example contributions of N-glycoproteomics to the understanding of membrane biology are provided, and the areas that require future technical breakthroughs are discussed.
Keywords: N-glycoproteomics, hydrazide chemistry, membrane, plasma membrane, membrane proteome
Membrane and Plasma Membrane Proteins and Their Analysis Techniques
The plasma membrane segregates a mammalian cell body from its environment.1 Proteins inserted in the plasma membrane help connect cells to their immediate environment by transporting nutrients and wastes, protecting cell integrity and facilitating cell motility and adhesion, and by sensing the environmental cues and eliciting appropriate responses. Inevitably, surface proteins play crucial roles in cell survival and fitness. Often membrane proteins can be proteolytically cleaved from the cell surface and shed into body fluids. As a result, circulating membrane proteins can be biomarkers for disease diagnosis and prognosis, and plasma membrane proteins are frequently targeted by drugs.
Functioning importantly at the interface, the plasma membrane is physically and chemically close connected to the endomembrane system and the extracellular environment.1,2 For example, cell surface proteins are synthesized and recycled through the secretory and endocytic pathways including the endoplasmic reticulum (ER) and Golgi apparatus complex as well as the endosomes and lysosomes. In the meantime, cells also modify their immediate environments and send various signals by secreting extracellular matrix components, small molecules, peptides, as well as microparticles and exosomes, as shown in Figure 1. Therefore, cellular membrane system in general, and plasma membrane in particular, are closely related, and this review will start from the techniques developed to analyze plasma membrane proteins and ends with a discussion about the intimacy between membrane and plasma membrane proteins, which pose significant challenges and opportunities for N-glycoproteomics.
Figure 1.

Composition and relationship of proteins in the N-glycoproteome.
Membrane proteins represent a diverse and poorly characterized protein category in the cell. Possibly due to the biological and physiological importance, current studies suggest that in many genomes including the human genome3,4 around one-third to half of the annotated genes5−7 encode membrane proteins. However, <1% of known protein structures in the Protein Data Bank (PDB) (http://www.rcsb.org/pdb/home/home.do, 2013 statistics) are derived from membrane proteins. Albeit large-scale proteomics efforts employing multidimensional separations that have been carried out to characterize cellular states and behaviors,8,9 membrane proteins are often under-represented.10 Moreover, a large number of surface receptors such as many G-protein-coupled receptors are expressed at extremely low level (<100 copies/cell11,12) that survey-based global proteomics studies often miss.13
The difficulty in studying plasma membrane proteins arises mainly from three factors. (1) Structural complexity. This complexity includes the heavy modifications on both the ecto- and endodomains of membrane proteins. In addition, membrane proteins tend to form homo- or heterodimers and oligomers that further increase the dimensionality of their structural complexity. (2) High diversity and low abundance. As mentioned above, membrane proteins occupy a larger percentage of the genome than other protein classes such as enzymes, cytoskeletal proteins, and proteins regulating translation and transcription. Nevertheless, membrane proteins only occupy less than 1% of the overall cellular protein mass. (3) Low solubility. Membrane proteins especially the integral membrane proteins have high hydrophobic transmembrane spans and hydrophilic domains and loops that heavily rely on interactions with lipid bilayers for appropriate folding. The removal of the lipids causes these proteins to collapse and forms aggregates that are difficult to dissolve in aqueous solutions without the help of detergents.
Because of these challenges, many analytical and bioanalytical techniques have been developed to assist proteomic characterization of plasma membrane proteins.14−19 Because most detection techniques are concentration-dependent, significant efforts have been focused on the enrichment of plasma-membrane proteins through solubilization and separation of the enriched proteins and their derived peptides.15,17−22 For enrichment and isolation, early efforts have involved using two-phase partition23,24 as well as continuous density-gradient technique.25,26 Concerns regarding the substantial organelle contaminations of plasma membrane proteins have been raised in the later applications of these methods.27,28 Ever since, more selective techniques to analyze cell-surface proteins have been developed using biotinylation29−31or colloidal-particle affinity binding of functional groups or antigen epitopes on the intact-cell surface.28,32−35 Enzymatic shedding (proteolytic cleavage) of cell-surface proteins is another clever method to specifically isolate protein domains on the external-surface of the plasma membrane.36−39 These methods still more or less suffer from the cytosolic protein contaminations arising from the natural cell death inherent to in vitro cell cultures. Additional separations of the enriched proteins and the proteolytic products by 2D-gel,40,41 SDS-PAGE/LC, or gel-free liquid chromatography17,42,43 and capillary electrophoresis44,45 have all been pursued. Most methods rely on peptide MS for protein identification and quantification. Because of the lack of proteolytic sites, different enzymes beyond trypsin have been explored to improve the digestion efficiency, including proteinase K46 and LysC,47 prior to MS detection. In the meantime, solubilization and denaturation conditions have also been extensively studied to strip lipids off the membrane proteins and aid the enzymatic digestion.19,20,48 Several excellent reviews have summarized the technical efforts in membrane proteomics.17,20,22,42
This review will, however, focus on a different strategy to enrich membrane and plasma-membrane proteins from the above-mentioned techniques, that is, the N-glycoproteomics. We will highlight the current trend and some future directions of this technology in its development and applications.
Glycosylation of Plasma Membrane Proteins
Most plasma membrane proteins are modified by two main types of glycosylation:49 N- and O-GalNAc glycosylation. In N-glycosylation, oligosaccharides are attached to the β-amide of the asparagine (Asn) in an Asn-Xxx-Ser/Thr consensus sequence (where Xxx can be any amino acid but not proline),50,51 whereas in O-GalNAc glycosylation, oligosaccharides are attached to the hydroxyl group of the Ser or Thr side chains. Both N- and O-GalNAc glycosylations modify selectively extracellular regions of the plasma membrane proteins. Specifically, the addition of N-glycans takes place cotranslationally in the ER52 to the nascent polypeptide chain, and the further processing and maturation of N-glycans are finished in the Golgi, while the O-GalNAc addition occurs in the Golgi.53 Most proteins in the ER–Golgi complex are glycosylated, and this modification has broad biological implications.54−57 They are known to assist protein folding, to stabilize protein structure, and to guide the sorting and trafficking of membrane proteins.58−61 Glycan moieties also protect membrane proteins from undesired enzymatic attacks and participate in signaling cascades, immune responses, and cell adhesion to mention just a few.54,62−64 Defects in glycosylation cause congenital disorders of glycosylation,65−67 and the complete abolishment of this modification is embryonically lethal.62,68
The prevalent glycosylation on cell surface offers a unique opportunity to enrich low-abundance surface proteins. Several techniques have been developed to capture N- or O-GalNAc glycoproteins, and these methods can be divided into three main categories based on the interaction forces. Group 1: Covalent bonding that can be further separated into reversible and irreversible covalent bonding. The reversible bonding can be formed through the boronic acid,69 which reacts with vicinal diols in native saccharides to generate cyclic boronate,70−74 whereas the irreversible bonding can be formed via the hydrazide chemistry with the aldehydes or ketones introduced in saccharides by oxidizing cis-diols using periodate75−79 or by metabolic oligosaccharide engineering and bioorthogonal chemistry.80−83 The metabolic incorporated bioorthogonal groups are more frequently used for imaging84 than glycoproteomics analysis. Ketones and aldehydes can also be introduced into saccharides through enzymatic engineering, which has been achieved to study GlcNAc proteome.85,86 The two later studies are not included in this review. Group 2: Affinity binding. Affinity forces can be generated by lectin–carbohydrate and antibody–antigen interactions as well as manually introduced affinity tags, for example, biotin and histags. Lectins are naturally existing carbohydrate binding proteins87,88 that have been frequently used to enrich specific types of glycoproteins,89,90 but they lack the comprehensiveness to bind all glycoproteins. Universal affinity binding can be achieved by introducing biotin or small-peptide tags, such as FLAG or histag, into sugar moieties through chemical reactions of hydrazide75 or bioorthogonal chemistry,84 as previously described. Group 3: Hydrophilic interactions or size exclusion separation.91,92 This group of methods separate glycosylated proteins and peptides from their nonglycosylated counterparts by chromatography based on the hydrophilic properties or the bulky structure of oligosaccharides. The representative column-filling materials for these types of separations include amine-derivatized resin (i.e., HILIC)93 or monolithic columns,94,95 TiO2 columns for sialioglycopeptides,94−97 graphitic carbon,98−101 as well as porous size exclusion resins102 for small glycopeptides, (such as those generated from pronase digestion).98−100 Other new techniques also include ion pairing–normal phase liquid chromatography (IP-NPLC) enrichment,103 and the use of hexapeptide to normalize glycoproteins.104 Most methods have been reported for both protein and peptide analyses.
The enriched glycoproteins or glycopeptides are not readily identified by MS compared with their unglycosylated cytosolic counterparts. The sugar attachment possesses high complexity and heterogeneity.105 The heterogeneity can arise not only from the glycan structure itself but also from the sites attaching to proteins. The same protein can be glycosylated at different sites that is usually termed macroheterogeneity, and each glycosite can carry different glycoforms, which is termed microheterogeneity. As a result, in SDS-PAGE, glycoproteins often form a smear rather than a single band; in MS analysis, complex spectra with low signal intensity are a characteristic of glycopeptides.106,107 The negative charges from abundant sialylation on terminal glycans can further reduce the MS signal in positive ion mode.
To facilitate the MS identification and quantification, we frequently removed oligosaccharide moieties from glycoproteins and glycopeptides after the enrichment. For N-glycosylation, the β-aspartylglycosylamine linkage can be selectively cleaved using peptide-N-glycosidase F (PNGase F),108 except for those moieties in which the root β-1,4-acetylglucosamine has been fucosylated. The sites of N-glycosylation are readily identified by the deamidation of sugar-modified asparagine in the triamino-acid consensus sequence. The reaction converts the asparagine to aspartic acid with a close to 1 Da mass shift108 (i.e., 0.9840 Da). Identification and quantification of the deglycosylated glycopeptides are then handled similarly as standard proteomics.109 Because no single enzyme can cleave O-GalNAc protein linkage, N-glycoproteomics is relatively easy and straightforward to pursue in comparison with O-glycoproteomics.
To completely remove O-GalNAc glycosylation, both a cocktail of glycosidases and chemical deglycosylation methods have been broadly employed individually or in combination.110−114 With the development of special MS fragmentation techniques such as IRMPD, ETD, and ECD,105,106,115,116 intact or partially deglycosylated peptide products are now possibly characterized. A recent bioengineering effort has remodeled in vivo O-GalNAc glycosylation pathway to yield “SimpleCell”,117 in which only one GalNAc is attached to the hydroxyl group of Ser/Thr side chains in the O-GalNAc proteins. This drastically simplifies the analyses of O-GalNAc glycoproteome.
The rest of this Review will detail the hydrazide-based N-glycoproteomics, with an emphasis on the methodology development for membrane and plasma-membrane protein characterization. In this context, we will discuss some critical and inherent issues, such as the comprehensiveness and selectivity of membrane and plasma-membrane proteins and the sensitivity and accuracy of the identification and quantification of proteins, their sites of modification, and their interaction with other molecules.
Hydrazide-Based N-Glycoproteomics
Among all protein-centric proteomics strategies for N-glycosylation, the hydrazide chemistry appears to achieve high comprehensiveness and specificity on glycoproteins.109,118 The high selectivity of this method is originated from the robust covalent bond, which can tolerate stringent wash conditions. The better removal of other macromolecule contamination through stringent washes helps the deep and comprehensive membrane proteomics analyses.
The selectivity of this method is based on the periodate oxidation of the cis-diols that are ubiquitous in carbohydrates, a reaction first described in 1950s.76 The newly formed aldehydes and ketones can then react with hydrazide under mild acidic conditions to form chemically stable hydrazones.75,77,79 The method gained popularity in 1980s as a means for labeling carbohydrates,79 and the first application of this method to immobilize proteins was carried out with antibodies.77 In 2003, Zhang et al. pioneered its use in proteomics analysis,109 in which glycoproteins were first immobilized on hydrazide-derived resins and then were digested into peptides. After the removal of the unbound ones, the N-glycopeptides were selectively released from the resin by PNGase F prior to LC–MS proteomics analyses. The protocol of this method has been documented.119
Later, this method was optimized into a one-tube reaction,120 in which the glycoproteins were first digested into peptides and then the oxidation, capture, and releasing steps can be carried out in one tube by using quencher to deactivate the excessive oxidants prior to the capture. A video protocol of this new method has been made available recently.2 The digestion of membrane proteins into peptides greatly improved the efficiency of bringing membrane proteins into aqueous solutions, and the one-tube procedure makes the analysis available to capture N-glycoproteins of low abundance. These improvements were reflected by the high selectivity (>90%) of both the N-glycoproteins and N-glycopeptides in the final result, which yielded the highest percentage of glyco-enrichment in membrane–protein applications. In addition to quenching, a desalting column has been used121 to remove excessive periodate after the initial protein digestion. Because the desalting step is more difficult to be integrated in a one-tube scheme, the method is more suitable for studies of a relatively large quantity of samples. The high glyco-selectivity (or specificity) in peptide-capture method has been verified later in many studies,12,122−124 and the optimized protocol can achieve a selectivity as high as 97–99%122 for soluble blood proteins and 95% for membrane proteins.2 The application of the one-tube peptide capture has helped to identify cancer cell-surface biomarkers,120 the N-glycoproteome of mouse embryonic stem cells,12 and so on. Ramachandran et al.125 applied both the one-tube peptide method and the previous protein method to the saliva samples and suggested that the number of identified proteins from both methods were similar; however, the false positives were greatly reduced in the one-tube peptide method. Because most saliva proteins are soluble proteins, this study indicated that even though the one-tube peptide capture was designed for membrane proteins, it can be applied to study soluble and secreted glycoproteomes with demonstrated benefits.
Several other improvements were also carried out to the hydrazide N-glycoproteomics. Enzymes, such as pepsin and thermolysin, have been utilized in combination of trypsin to effectively digest membrane proteins.126 For the enlarged capture area and the ease of operation, the agarose resins used in the original protein/peptide capture have been replaced by paramagnetic nanoparticles.122,127,128 The capture step itself has been performed in the regular microcentrifuge vials as well as in spin-filter columns122 and the recent microspin-filter columns, such as stage-tips.129 To improve the accuracy in mapping the N-glycosites, the PNGase F deglycosylation has been performed in 18O-labeled water, as introduced initially in 1992 by Gonzalez et al. to free glycoproteins130 and later by Kuster and Mann in 1999 to gel-separated glycoproteins.131 In this step, the 18O in water is incorporated in the deglycosylated peptides, causing a mass shift of +2.9840 Da as opposed to the 0.9840 Da shift formed in regular 16O water. Kaji et al. implemented this deglycosylation strategy in their lectin-based N-glycoproteomics in 2003,132 and this labeling has been integrated with hydrazide N-glycoproteomics by various researchers.133,134 Besides 18O-labeled water, endo-β-N-acetylglucosaminidases (EC 3.2.1.96) were also used in the none-hydrazide N-glycoproteomics135 to cleave the glycosidic bond between the two proximal N-acetylglucosamines (GlcNAc) in the pentasaccharide core and to resolve peptides carrying a large mass shift of 203.08 Da (or 349.14 Da for the fucosylated saccharide)136137 that can be easily distinguished from nonglycosylated peptides by MS.
Integrated N-Glycoproteomics Methods
The low abundance of membrane proteins demands the most sensitive analytical techniques to improve their characterization efficiency. Integrated and online analyses will without doubt benefit the studies of low abundance proteins. The hydrazide-based capture often involves several steps, and some of them can be combined into a one-tube protocol as previously addressed, yet it is still challenging to conduct the whole procedure in a single vessel or online prior to MS analysis. In this case, other N-glycoproteomics studies have been more advanced. For instance, the lectin-coupled filter-aided sample preparation (N-glycol-FASP) method developed in Mann’s group can achieve one-tube N-glycoproteomics and has been implemented to study many different biological species.138 Besides lectin, Ti-IMAC-based FASP has also been reported for the integrated N-glycoproteomics.139 A flexible online proteomics reactor was developed in Figeys’ lab140 and was recently demonstrated to have the capacity to combine all steps of the lectin enrichment, 18O-isotopic-labeling, deglycosylation, and trypsin digestion online with the multidimensional liquid chromatography separation and MS for N-glycoproteomics analysis. Automatic online separation integrating HILIC or graphitic carbon for glycopeptides enrichment has also been developed for the N-glycoproteomics.141,142
N-Glycoproteomics for Plasma Membrane Proteins
The plasma membrane is intimately related to the endomembrane system as well as the extracellular matrix and fluids. A majority of these membranes have most of their resident proteins N-glycosylated. Whole-cell hydrazide N-glycoproteomics does not distinguish plasma-membrane N-glycoproteins from those localized in other membranes. Hydrazide-based cell surface capture (CSC)118was developed and applied to the intact cells to achieve the surface selectivity. Because of the cytotoxicity raised by periodate and the endocytosis of intact cells, the labeling of glycoproteins in the secretory pathways had been observed in the CSC method. Mild periodate oxidization of surface sialic acids was subsequently developed and performed at a lower temperature to minimize endocytosis and to achieve the high selection of plasma membrane proteins.83 Studies have also compared the surface proteome obtained by hydrazide chemistry with those from the biotinylation of all surface membrane proteins.143,144 The results suggest a complementarity between the two methods, yet the N-glycocapture is able to identify post-translational modifications but not the biotinylation method.144
Comparison of Different Methods
With the rapid advancement of glycoprotein analyses, numerous biological applications have been published. There is an urgent need to compare the results obtained among different methods for their pros and cons, a piece of information that is important to guide researchers in biological fields to choose and design an appropriate strategy for their specific research interests. All studies thus far have reported the total number of the identified proteins, but it is difficult to compare only these numbers due to various differences in the biological samples, the parameters used in analysis, and the applied methods themselves. We attempted to assess the GO (gene ontology)-enrichment p value instead of just the number of protein identification among several published results to reveal their similarities and differences in our recent study of the N-glycoproteome of mouse embryonic stem (mES) cells.12 In this study, we compared our N-glycoproteome with the published global proteome and transcriptome of mES cells, as well as with other membrane proteomes obtained by differential centrifugation, surface–protein biotinylation, and the CSC method. GO enrichment analysis has been frequently used to identify the biological nature of the sample, and the biological difference among samples; however, it is rarely used for the comparison of different methods. The heatmap visualization we used in the study of mES-cell N-glycoproteome helped discover the patterns formed across different analysis methods, and the use of the same set of GO terms unified the comparison criteria. This analysis allowed us to reveal technical concerns raised by the original authors as well as the known biological difference in the used samples. This exercise demonstrated that it is possible to disclose pros and cons from different studies using bioinformatics, an analysis that not only saves the time and cost of experimentally reproducing the published work but also can maximize the usage of existing data.
Dynamics of Plasma Membrane Proteins
Plasma membrane proteins are highly dynamic. Both their composition and their post-translational modifications are constantly being remodeled by the extracellular environment as well as the intracellular molecular machinery. Using N-glycoproteomics, researchers have gained fundamental insights into these dynamics. For example, using the whole N-glycoproteomics and CSC, the desensitization after stimulation has been characterized by the internalization of cell surface receptors.145 Glycosylation can also be used to monitor the onset and progression of diseases. Metastatic cancer tissues are known to carry distinct glycan moieties than those from normal population,146,147 and N-glycoproteomics has contributed greatly to the characterization of these changes and to the discovery of biomarkers in disease diagnosis, prognosis, and in patient responses to treatments. Details can be found in several excellent reviews.148−150 During evolution, such as speciation, and biological development processes, such as embryogenesis and organogenesis, profound changes in surface–protein glycosylation have been known, and N-glycoproteomics is actively pursued to systematically characterize the similarity and differences among species, organs, tissues, and cell types.118,138,151,152 An evolutionarily conserved complementarity between transmembrane domain and N-glycosylation has also been discovered recently in a comparison of five different animal species including human, mouse, fish, fly, and worm using N-glycoproteomics.12
Landscape of Plasma Membrane Proteins
From genomic information, we know the cell surface is rich in various glycoproteins, such as receptors, adhesion molecules, transporters, ion channels, and enzymes. However, we know little about their overall abundance in terms of both the absolute quantity and the quantity relative to each other. Our recent survey of the N-glycoproteome of mouse embryonic stem cells offers unique quantitative information at the molecular resolution on the protein landscape of cell surface. Using the mutually exclusive cataloguing scheme defined by Almen et al.,153 our study summarized membrane proteins into four categories, that is, receptor, transporter, enzyme, and miscellaneous,12 in which the transporters had the highest expression levels, whereas the receptors exhibited the largest diversity. On the basis of the results, the composition of surface proteins can be shown in Figure 2, where the receptors are twice as diverse as the transporters, yet the transporters express at two times higher quantity than any other protein category on the membrane. This global experimental information helps materialize our conceptual understanding of the cell surface proteins and also helps elucidate the related cellular physiology and biology. High-throughput proteomics encompasses enormous data such that studies aiming to mine and to analyze these data from different perspectives should be greatly encouraged. These computational efforts will also maximize the scientific value of the obtained results.
Figure 2.

Illustration of major membrane glycoproteins, in which the red dots represent glycans: E, enzyme; R, receptor; T, transporter.
The structure and function of membrane proteins are heavily influenced by their interaction partners including those from the extracellular matrix and cytosolic scaffolds, for example. These interactions have been recently characterized systematically in yeast.154 In this study, Babu et al. have researched four types of detergents to obtain membrane protein–protein interactions with various strengths.154 A daunting total of 1726 membrane protein–protein interactions were individually studied, and the acquired information is an invaluable addition to our understanding of membrane proteins.
Linking N-Glycoproteome Back to the Proteome
Membrane proteins are biologically, physically, and chemically important to study, yet it is necessary and important to view their dynamics and functions together with the rest of the proteome. Previously, the membrane proteome has been a critical part in the whole proteome analysis. Nevertheless, most N-glycoproteomics efforts reviewed here have been primarily focused on the N-glycoproteome itself. New studies have emerged to examine the overall proteome together with the N-glycoproteome.123,155 Within such a strategy, the capture approach has been used as a separation procedure instead of merely an enrichment step. An application of such an strategy termed: glycocapture-assisted global quantitative proteomics (gagQP), to the blood toxicoproteome has successfully identified more than 20 organ-specific biomarkers, indicating the toxic response of drug in eight organs.123
Remarks
Biological membranes possess unique and critical functions in a cell; the proteins in the membrane have been an indispensable component of membrane structure and function, and they play crucial roles in modern medicine. Proteomics have been an effective tool to directly interrogate membrane proteins. The low abundance and the special localization of membrane proteins will constantly challenge the sensitivity and accuracy of any proteomics approach. In the past 10 years, the instrumentation of capillary nanoflow high-performance liquid chromatography and mass spectrometry has been quickly advanced. These efforts significantly improved our capacity to detect low-abundance membrane proteins and advanced the penetration of the membrane proteomes. Interestingly, one logical drawback arising from these instrumental improvements is an increased identification of the undesired contamination in the results, which motivates the development of more selective strategies.
Different methods introduced here will coexist due to their unique characteristics in sensitivity, selectivity, coverage, and ease of use. It is important to design and choose an appropriate strategy or a combination of a set of techniques based on the defined biological questions. Among all N-glycoproteomics strategies for membrane proteins, the chemical covalent bonding by the hydrazide chemistry potentially possesses the best selectivity through its tolerance to stringent washes. The nonhydrazide methods are readily employed for one-vessel or online N-glycoproteomics that offers better sensitivity than off-line approaches with multiple isolated steps. The increased precision to selecting a particular cell component, such as the plasma membrane, will eliminate the membrane proteins in the secretary and endocytic pathways that are trafficking toward or away from this site. This elimination will decrease the coverage of plasma membrane proteome, particularly the traveling low-abundance membrane proteins, yet this fundamental conflict is similar to the “uncertain theory” in quantum physics that may never be completely resolved.
The static examinations of membrane and plasma membrane proteins are likely replaced in the near future by the spatially and temporally resolved dynamic studies of membrane protein and their post-translational modifications. The mapping of the N-glycosylation sites has been a relative straightforward task compared with that of the O-glycosylation partially due to the available endoglycosidases. However, a recent report on the potential chemical deamidation156 has confounded the enzymatic deglycosylation pursued in both 18O- and 16O-labeled water. Therefore, the use of additional endohydrolases, such as endo-β-N-acetylglucosaminidases, will be a useful alternative. The dynamics of N-glycoproteome including both the N-glycoproteins and their sites of N-glycosylation will be better understood by the rapid development of quantitative proteomics.157−162 All major quantitative proteomics strategies including isotope labeling and label-free analyses and the targeted multiple-reaction monitoring have been coupled to the N-glycoproteomics.109,123,145,163
More hybrid analyses combining different methods in sequel or in parallel have emerged to improve their effectiveness to address biological questions.164 Computer informatics will be increasingly important to mine vast proteomics data sets and recognize the hidden patterns. The new problems arising from these endeavors should propel the technological innovations, and the pioneering analytical and bioanalytical tools will constantly push the frontiers of membrane glycoprotein research and provide fundamental molecular insights for human health and wellbeing.
Acknowledgments
We acknowledge all colleagues pursuing research in the glycoproteomics field. Their efforts and expertise have put glycobiology as one of the forefronts of biology. The space and scope of this review can cover only part of this vibrant field. If there is any missing recognition of the contributions, it is because of the limitation of this review. The past and present funding has supported the authors including those from National Institutes of Health, National Science Foundation, Department of Defense, Canadian Foundation of Innovation, Stem Cell Network, British Columbia Proteomics Network, Computing Canada, and Simon Fraser University.
The authors declare no competing financial interest.
Funding Statement
National Institutes of Health, United States
References
- Petty H. R.Molecular Biology of Membranes: Structure and Function; Plenum Press: New York, 2007. [Google Scholar]
- Lee G. M.-C.; Sun B. Glycopeptide capture for cell surface proteomics. J. Visualized Exp. 2014, 10.3791/51349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lander E. S.; Linton L. M.; Birren B.; Nusbaum C.; Zody M. C.; Baldwin J.; et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860–921. [DOI] [PubMed] [Google Scholar]
- Ahram M.; Litou Z. I.; Fang R.; Al-Tawallbeh G. Estimation of membrane proteins in the human proteome. In Silico Biol. 2006, 65379–386. [PubMed] [Google Scholar]
- Wallin E.; von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 1998, 7, 1029–1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krogh A.; Larsson B.; von Heijne G.; Sonnhammer E. L. Predicting transmembrane protein topology with a hidden markoc model: Application to complete genomes. J. Mol. Biol. 2001, 305, 567–580. [DOI] [PubMed] [Google Scholar]
- Kanapin A.; Batalov S.; Davis M. J.; Gough J.; et al. Mouse proteome analysis. Genome Res. 2003, 13, 1335–1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mann M.; Kulak N. A.; Nagaraj N.; Cox J. The coming age of complete, accurate, and ubiquitous proteomes. Mol. Cell 2013, 494583–590. [DOI] [PubMed] [Google Scholar]
- Mallick P.; Kuster B. Proteomics: A pragmatic perspective. Nat. Biotechnol. 2010, 287695–709. [DOI] [PubMed] [Google Scholar]
- Graumann J.; Hubner N. C.; Kim J. B.; Ko K.; Moser M.; Kumar C.; Cox J.; Scholer H.; Mann M. Stable isotope labeling by amino acids in cell culture (silac) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol. Cell. Proteomics 2008, 74672–683. [DOI] [PubMed] [Google Scholar]
- Hilton D. J.; Nicola N. A. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J. Biol. Chem. 1992, 2671510238–10247. [PubMed] [Google Scholar]
- Sun B.; Ma L.; Yan X.; Lee D.; Alexander V.; Hohmann L. J.; Lorang C.; Chandrasena L.; Tian Q.; Hood L. N-glycoproteome of e14.Tg2a mouse embryonic stem cells. PLoS One 2013, 82e55722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lundberg E.; Fagerberg L.; Klevebring D.; Matic I.; Geiger T.; Cox J.; Algenas C.; Lundeberg J.; Mann M.; Uhlen M. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6, 450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wisniewski J. R. Tools for phospho- and glycoproteomics of plasma membranes. Amino Acids 2011, 412223–233. [DOI] [PubMed] [Google Scholar]
- Tan S.; Tan H. T.; Chung M. C. Membrane proteins and membrane proteomics. Proteomics 2008, 8193924–3932. [DOI] [PubMed] [Google Scholar]
- Savas J. N.; Stein B. D.; Wu C. C.; Yates J. R. 3rd Mass spectrometry accelerates membrane protein analysis. Trends Biochem. Sci. 2011, 367388–396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu B.; McClatchy D. B.; Kim J. Y.; Yates J. R. 3rd Strategies for shotgun identification of integral membrane proteins by tandem mass spectrometry. Proteomics 2008, 8193947–3955. [DOI] [PubMed] [Google Scholar]
- Griffin N. M.; Schnitze J. E. Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissuees. Mol. Cell. Proteomics 2011, 10, 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dormeyer W.; van Hoof D.; Mummery C. L.; Krijgsveld J.; Heck A. J. A practical guide for the identification of membrane and plasma membrane proteins in human embryonic stem cells and human embryonal carcinoma cells. Proteomics 2008, 8194036–4053. [DOI] [PubMed] [Google Scholar]
- Speers A. E.; Wu C. C. Proteomics of integral membrane proteins-theory and application. Chem. Rev. 2007, 107, 3687–3714. [DOI] [PubMed] [Google Scholar]
- Helbig A. O.; Heck A. J.; Slijper M. Exploring the membrane proteome--challenges and analytical strategies. J. Proteomics 2010, 735868–878. [DOI] [PubMed] [Google Scholar]
- Cordwell S. J.; Thingholm T. E. Technologies for plasma membrane proteomics. Proteomics 2010, 104611–627. [DOI] [PubMed] [Google Scholar]
- Schindler J.; Lewandrowski U.; Sickmann A.; Friauf E.; Nothwang H. G. Proteomic analysis of brain plasma membranes isolated by affinity two-phase partitioning. Mol. Cell. Proteomics 2006, 52390–400. [DOI] [PubMed] [Google Scholar]
- Cao R.; Li X.; Liu Z.; Peng X.; Hu W.; Wang X.; Chen P.; Xie J.; Liang S. Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins. J. Proteome Res. 2006, 53634–642. [DOI] [PubMed] [Google Scholar]
- Navarre C.; Degand H.; Bennett K. L.; Crawford J. S.; Mortz E.; Boutry M. Subproteomics: Identification of plasma membrane proteins from the yeast saccharomyces cerevisiae. Proteomics 2002, 2121706–1714. [DOI] [PubMed] [Google Scholar]
- Adam P. J.; Boyd R.; Tyson K. L.; Fletcher G. C.; Stamps A.; Hudson L.; Poyser H. R.; Redpath N.; Griffiths M.; Steers G.; Harris A. L.; Patel S.; Berry J.; Loader J. A.; Townsend R. R.; Daviet L.; Legrain P.; Parekh R.; Terrett J. A. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 2003, 27886482–6489. [DOI] [PubMed] [Google Scholar]
- Zhang W.; Zhou G.; Zhao Y.; White M. A. Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis 2003, 24162855–2863. [DOI] [PubMed] [Google Scholar]
- Chang P. S.; Absood A.; Linderman J. J.; Omann G. M. Magnetic bead isolation of neutrophil plasma membranes and quantification of membrane-associated guanine nucleotide binding proteins. Anal. Biochem. 2004, 3252175–184. [DOI] [PubMed] [Google Scholar]
- Zhao Y.; Zhang W.; Kho Y.; Zhao Y. Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 2004, 76, 1817–1823. [DOI] [PubMed] [Google Scholar]
- Sostaric E.; Georgiou A. S.; Wong C. H.; Watson P. F.; Holt W. V.; Fazeli A. Global profiling of surface plasma membrane proteome of oviductal epithelial cells. J. Proteome Res. 2006, 5113029–3037. [DOI] [PubMed] [Google Scholar]
- Nunomura K.; Nagano K.; Itagaki C.; Taoka M.; Okamura N.; Yamauchi Y.; Sugano S.; Takahashi N.; Izumi T.; Isobe T. Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol. Cell. Proteomics 2005, 4121968–1976. [DOI] [PubMed] [Google Scholar]
- Schnitzer J. E.; McIntosh D. P.; Dvorak A. M.; Liu J.; Oh P. Separation of caveolae from associated microdomains of gpi-anchored proteins. Science 1995, 26952291435–1439. [DOI] [PubMed] [Google Scholar]
- Oh P.; Li Y.; Yu J.; Durr E.; Krasinska K. M.; Carver L. A.; Testa J. E.; Schnitzer J. E. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004, 4296992629–635. [DOI] [PubMed] [Google Scholar]
- Lawson E. L.; Clifton J. G.; Huang F.; Li X.; Hixson D. C.; Josic D. Use of magnetic beads with immobilized monoclonal antibodies for isolation of highly pure plasma membranes. Electrophoresis 2006, 27132747–2758. [DOI] [PubMed] [Google Scholar]
- Chaney L. K.; Jacobson B. S. Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J. Biol. Chem. 1983, 2581610062–10072. [PubMed] [Google Scholar]
- Tjalsma H.; Lambooy L.; Hermans P. W.; Swinkels D. W. Shedding & shaving: Disclosure of proteomic expressions on a bacterial face. Proteomics 2008, 871415–1428. [DOI] [PubMed] [Google Scholar]
- Speers A. E.; Blackler A. R.; Wu C. C. Shotgun analysis of integral membrane proteins facilitated by elevated temperature. Anal. Chem. 2007, 79124613–4620. [DOI] [PubMed] [Google Scholar]
- Solis N.; Cordwell S. J. Current methodologies for proteomics of bacterial surface-exposed and cell envelope proteins. Proteomics 2011, 11153169–3189. [DOI] [PubMed] [Google Scholar]
- Rodriguez-Ortega M. J.; Norais N.; Bensi G.; Liberatori S.; Capo S.; Mora M.; Scarselli M.; Doro F.; Ferrari G.; Garaguso I.; Maggi T.; Neumann A.; Covre A.; Telford J. L.; Grandi G. Characterization and identification of vaccine candidate proteins through analysis of the group a streptococcus surface proteome. Nat. Biotechnol. 2006, 242191–197. [DOI] [PubMed] [Google Scholar]
- Zhang L. J.; Wang X. E.; Peng X.; Wei Y. J.; Cao R.; Liu Z.; Xiong J. X.; Yin X. F.; Ping C.; Liang S. Proteomic analysis of low-abundant integral plasma membrane proteins based on gels. Cell. Mol. Life Sci. 2006, 63151790–1804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bunai K.; Yamane K. Effectiveness and limitation of two-dimensional gel electrophoresis in bacterial membrane protein proteomics and perspectives. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 8151–2227–236. [DOI] [PubMed] [Google Scholar]
- Rabilloud T. Membrane proteins ride shortgun. Nat. Biotechnol. 2003, 21, 508–510. [DOI] [PubMed] [Google Scholar]
- Gilmore J. M.; Washburn M. P. Advances in shotgun proteomics and the analysis of membrane proteomes. J. Proteomics 2010, 73112078–2091. [DOI] [PubMed] [Google Scholar]
- Wang W.; Guo T.; Song T.; Lee C. S.; Balgley B. M. Comprehensive yeast proteome analysis using a capillary isoelectric focusing-based multidimensional separation platform coupled with esi-ms/ms. Proteomics 2007, 781178–1187. [DOI] [PubMed] [Google Scholar]
- Wang W.; Guo T.; Rudnick P. A.; Song T.; Li J.; Zhuang Z.; Zheng W.; Devoe D. L.; Lee C. S.; Balgley B. M. Membrane proteome analysis of microdissected ovarian tumor tissues using capillary isoelectric focusing/reversed-phase liquid chromatography-tandem ms. Anal. Chem. 2007, 7931002–1009. [DOI] [PubMed] [Google Scholar]
- Wu C. C.; MacCoss M. J.; Howell K. E.; Yates J. R. 3rd A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 2003, 215532–538. [DOI] [PubMed] [Google Scholar]
- Olsen J. V.; Andersen J. R.; Nielsen P. A.; Nielsen M. L.; Figeys D.; Mann M.; Wisniewski J. R. Hystag--a novel proteomic quantification tool applied to differential display analysis of membrane proteins from distinct areas of mouse brain. Mol. Cell. Proteomics 2004, 3182–92. [DOI] [PubMed] [Google Scholar]
- Vuckovic D.; Dagley L. F.; Purcell A. W.; Emili A. Membrane proteomics by high performance liquid chromatography-tandem mass spectrometry: Analytical approaches and challenges. Proteomics 2013, 133–4404–423. [DOI] [PubMed] [Google Scholar]
- Valki A.; Cummings R.; Esko J. D.; Freeze H. H.; Stanley P.; Bertozzi C. R.; Hart G. W.; Etzler M. E.. Essentials of Glycobiology, 2nd ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009. [PubMed] [Google Scholar]
- Bause E.; Hettkamp H. Primary structural requirements for n-glycosylation of peptides in rat liver. FEBS Lett. 1979, 1082341–344. [DOI] [PubMed] [Google Scholar]
- Marshall R. D. The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem Soc. Symp. 1974, 4017–26. [PubMed] [Google Scholar]
- Kornfeld R.; Kornfeld S. Assembly of n-asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54, 631–664. [DOI] [PubMed] [Google Scholar]
- Hang H. C.; Bertozzi C. R. The chemistry and biology of mucin-type o-linked glycosylation. Bioorg. Med. Chem. 2005, 13175021–5034. [DOI] [PubMed] [Google Scholar]
- Varki A. Factors controlling the glycosylation potential of the golgi apparatus. Trends Cell Biol. 1998, 8, 34–40. [DOI] [PubMed] [Google Scholar]
- Varki A. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 1993, 3297–130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lis H.; Sharon N. Protein glycosylation structure and function. Eur. J. Biochem. 1993, 218, 1–27. [DOI] [PubMed] [Google Scholar]
- Dwek R. A. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 1996, 962683–720. [DOI] [PubMed] [Google Scholar]
- Parodi A. J. Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 2000, 69, 69–93. [DOI] [PubMed] [Google Scholar]
- Petrescu A. J.; Wormald M. R.; Dwek R. A. Structural aspects of glycomes with a focus on n-glycosylation and glycoprotein folding. Curr. Opin. Struct. Biol. 2006, 165600–607. [DOI] [PubMed] [Google Scholar]
- Roth J.; Zuber C.; Park S.; Jang I.; Lee Y.; Kysela K. G.; Le Fourn V.; Santimaria R.; Guhl B.; Cho J. W. Protein n-glycosylation, protein folding, and protein quality control. Mol. Cells 2010, 306497–506. [DOI] [PubMed] [Google Scholar]
- Vagin O.; Kraut J. A.; Sachs G. Role of n-glycosylation in trafficking of apical membrane proteins in epithelia. Am. J. Physiol: Renal Physiol 2009, 296, F459–F469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haltiwanger R. S.; Lowe J. B. Role of glycosylation in development. Annu. Rev. Biochem. 2004, 73, 491–537. [DOI] [PubMed] [Google Scholar]
- Janik M. E.; Litynska A.; Vereecken P. Cell migration-the role of integrin glycosylation. Biochim. Biophys. Acta 2010, 18006545–555. [DOI] [PubMed] [Google Scholar]
- Zhao Y.; Sato Y.; Isaji T.; Fukuda T.; Matsumoto A.; Miyoshi E.; Gu J.; Taniguchi N. Branched n-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008, 27591939–1948. [DOI] [PubMed] [Google Scholar]
- Dennis J. W.; Lau K. S.; Demetriou M.; Nabi I. R. Adaptive regulation at the cell surface by n-glycosylation. Traffic 2009, 10111569–1578. [DOI] [PubMed] [Google Scholar]
- Freeze H. H.; Aebi M. Altered glycan structures: The molecular basis of congenital disorders of glycosylation. Curr. Opin. Struct. Biol. 2005, 155490–498. [DOI] [PubMed] [Google Scholar]
- Hennet T. Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim. Biophys. Acta 2012, 182091306–1317. [DOI] [PubMed] [Google Scholar]
- Dennis J. W.; Granovsky M.; Warren C. E. Protein glycosylation in development and disease. BioEssays 1999, 21, 412–421. [DOI] [PubMed] [Google Scholar]
- Bond M. R.; Kohler J. J. Chemical methods for glycoprotein discovery. Curr. Opin Chem. Biol. 2007, 11152–58. [DOI] [PubMed] [Google Scholar]
- Dowlut M.; Hall D. G. An improved class of sugar-binding boronic acids, soluable and capable of complexing glycosides in neutral water. J. Am. Chem. Soc. 2006, 128, 4226–4227. [DOI] [PubMed] [Google Scholar]
- James T. D.; Sandanayake K. R. A. S.; Shinkai S. Saccharide sensing with molecular recetpros based on boronic acid. Angew. Chem., Int. Ed. Engl. 1996, 35, 1910–1922. [Google Scholar]
- Lorand J. P.; Edwards J. O. Polyol complexes and structure of the benzeneboronate ion. J. Org. Chem. 1959, 24, 769–774. [Google Scholar]
- Tang J.; Liu Y.; Qi D.; Yao G.; Deng C.; Zhang X. On-plate-selective enrichment of glycopeptides using boronic acid-modified gold nanoparticles for direct maldi-qit-tof ms analysis. Proteomics 2009, 9225046–5055. [DOI] [PubMed] [Google Scholar]
- Xu Y.; Wu Z.; Zhang L.; Lu H.; Yang P.; Webley P. A.; Zhao D. Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica. Anal. Chem. 2009, 811503–508. [DOI] [PubMed] [Google Scholar]
- Bayer E. A.; Ben-Hur H.; Wilchek M. Biocytin hydrazide--a selective label for sialic acids, galactose, and other sugars in glycoconjugates using avidin-biotin technology. Anal. Biochem. 1988, 1702271–281. [DOI] [PubMed] [Google Scholar]
- Bobbitt J. M. Periodate oxidation of carbohydrates. Adv. Carbohydr. Chem. 1956, 48111–41. [DOI] [PubMed] [Google Scholar]
- O’Shannessy D. J.; Dobersen M. J.; Quarles R. H. A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties. Immunol. Lett. 1984, 85273–277. [DOI] [PubMed] [Google Scholar]
- Roffman E.; Meromsky L.; Ben-Hur H.; Bayer E. A.; Wilchek M. Selective labeling of functional groups on membrane proteins or glycoproteins using reactive biotin derivatives and 125i-streptavidin. Biochem. Biophys. Res. Commun. 1986, 136180–85. [DOI] [PubMed] [Google Scholar]
- Wilchek M.; Bayer E. A. Labeling glycoconjugates with hydrazide reagents. Methods Enzymol 1987, 138, 429–442. [DOI] [PubMed] [Google Scholar]
- Mahal L. K.; Yarema K. J.; Bertozzi C. R. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 1997, 27653151125–1128. [DOI] [PubMed] [Google Scholar]
- Saxon E.; Bertozzi C. R. Chemical and biological strategies for engineering cell surface glycosylation. Annu. Rev. Cell Dev. Biol. 2001, 17, 1–23. [DOI] [PubMed] [Google Scholar]
- Yarema K. J.; Mahal L. K.; Bruehl R. E.; Rodriguez E. C.; Bertozzi C. R. Metabolic delivery of ketone groups to sialic acid residues: Application to cell surface glycoform engineering. J. Biol. Chem. 1998, 2734731168–31179. [DOI] [PubMed] [Google Scholar]
- Zeng Y.; Ramya T. N.; Dirksen A.; Dawson P. E.; Paulson J. C. High-efficiency labeling of sialylated glycoproteins on living cells. Nat. Methods 2009, 63207–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laughlin S. T.; Agard N. J.; Baskin J. M.; Carrico I. S.; Chang P. V.; Ganguli A. S.; Hangauer M. J.; Lo A.; Prescher J. A.; Bertozzi C. R. Metabolic labeling of glycans with azido sugars for visualization and glycoproteomics. Methods Enzymol. 2006, 415, 230–250. [DOI] [PubMed] [Google Scholar]
- Khidekel N.; Ficarro S. B.; Peter M. C.; Marian C. B.; Swaney D. L.; Rexach J. E.; Sun Y. E.; Coon J. J.; Peters E. C.; Hsieh-Wilson L. C. Probing the dynamics of o-glcnac glycosylation in the brain using quantitative proteomics. Nat. Chem. Biol. 2007, 36339–348. [DOI] [PubMed] [Google Scholar]
- Khidekel N.; Ficarro S. B.; Peters E. C.; Hsieh-Wilson L. C. Exploring the o-glcnac proteome: Direct identification of o-glcnac-modified proteins from the brain. Proc. Natl. Acad. Sci. U. S. A. 2004, 1013613132–13137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee Y. C.; Lee R. T. Carbohydrate-protein interactions: Basis of glycobiology. Acc. Chem. Res. 1995, 28, 321–327. [Google Scholar]
- Lis H.; Sharon N. Lectins: Carbohydrate-specific proteins that mediate cellular recognition. Chem. Rev. 1998, 98, 637–674. [DOI] [PubMed] [Google Scholar]
- Drake R. R.; Schwegler E. E.; Malik G.; Diaz J.; Block T.; Mehta A.; Semmes O. J. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 2006, 5101957–1967. [DOI] [PubMed] [Google Scholar]
- Fanayan S.; Hincapie M.; Hancock W. S. Using lectins to harvest the plasma/serum glycoproteome. Electrophoresis 2012, 33121746–1754. [DOI] [PubMed] [Google Scholar]
- Novotny M. V.; Alley W. R. Jr.; Mann B. F. Analytical glycobiology at high sensitivity: Current approaches and directions. Glycoconjugate J. 2013, 30289–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novotny M. V.; Mechref Y. New hyphenated methodologies in high-sensitivity glycoprotein analysis. J. Sep. Sci. 2005, 28151956–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alpert A. J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 1990, 499, 177–196. [DOI] [PubMed] [Google Scholar]
- Palmisano G.; Lendal S. E.; Engholm-Keller K.; Leth-Larsen R.; Parker B. L.; Larsen M. R. Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by hilic and mass spectrometry. Nat. Protoc. 2010, 5121974–1982. [DOI] [PubMed] [Google Scholar]
- Larsen M. R.; Jensen S. S.; Jakobsen L. A.; Heegaard N. H. Exploring the sialiome using titanium dioxide chromatography and mass spectrometry. Mol. Cell. Proteomics 2007, 6101778–1787. [DOI] [PubMed] [Google Scholar]
- Engholm-Keller K.; Larsen M. R. Titanium dioxide as chemo-affinity chromatographic sorbent of biomolecular compounds--applications in acidic modification-specific proteomics. J. Proteomics 2011, 752317–328. [DOI] [PubMed] [Google Scholar]
- Cao W.; Cao J.; Huang J.; Zhang L.; Yao J.; Xu H.; Yang P. Enhanced n-glycosylation site exploitation of sialoglycopeptides by peptide ipg-ief assisted tio2 chromatography. Glycoconjugate J. 2012, 295–6433–443. [DOI] [PubMed] [Google Scholar]
- An H. J.; Peavy T. R.; Hedrick J. L.; Lebrilla C. B. Determination of n-glycosylation sites and site heterogeneity in glycoproteins. Anal. Chem. 2003, 75205628–5637. [DOI] [PubMed] [Google Scholar]
- Dodds E. D.; Seipert R. R.; Clowers B. H.; German J. B.; Lebrilla C. B. Analytical performance of immobilized Pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics. J. Proteome Res. 2009, 82502–512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nwosu C. C.; Seipert R. R.; Strum J. S.; Hua S. S.; An H. J.; Zivkovic A. M.; German B. J.; Lebrilla C. B. Simultaneous and extensive site-specific n- and o-glycosylation analysis in protein mixtures. J. Proteome Res. 2011, 1052612–2624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Packer N. H.; Lawson M. A.; Jardine D. R.; Redmond J. W. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconjugate J. 1998, 158737–747. [DOI] [PubMed] [Google Scholar]
- Alvarez-Manilla G.; Atwood J. A.; Guo Y.; Warren N. L.; Orlando R.; Pierce M. Tools for glycoproteomic analysis: Size exclusion chromatography facilitates identification of tryptic glycopeptides with n-linked glycosylation sites. J. Proteome Res. 2006, 53701–708. [DOI] [PubMed] [Google Scholar]
- Ding W.; Nothaft H.; Szymanski C. M.; Kelly J. Identification and quantification of glycoproteins using ion-pairing normal-phase liquid chromatography and mass spectrometry. Mol. Cell. Proteomics 2009, 892170–2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huhn C.; Ruhaak L. R.; Wuhrer M.; Deelder A. M. Hexapeptide library as a universal tool for sample preparation in protein glycosylation analysis. J. Proteomics 2012, 7551515–1528. [DOI] [PubMed] [Google Scholar]
- North S. J.; Hitchen P. G.; Haslam S. M.; Dell A. Mass spectrometry in the analysis of n-linked and o-linked glycans. Curr. Opin. Struct. Biol. 2009, 195498–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dodds E. D. Gas-phase dissociation of glycosylated peptide ions. Mass Spectrom Rev. 2012, 316666–682. [DOI] [PubMed] [Google Scholar]
- Wada Y.; Tajiri M.; Yoshida S. Hydrophilic affinity isolation and maldi multi-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal. Chem. 2004, 76, 6560–6565. [DOI] [PubMed] [Google Scholar]
- Carr S. A.; Roberts G. D. Carbohydrate mapping by mass spectrometry: A novel method for identifying attachment sites of asn-linked sugars in glycoproteins. Anal. Biochem. 1986, 1572396–406. [DOI] [PubMed] [Google Scholar]
- Zhang H.; Li X. J.; Martin D. B.; Aebersold R. Identification and quantification of n-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 216660–666. [DOI] [PubMed] [Google Scholar]
- Mirgorodskaya E.; Hassan H.; Clausen H.; Roepstorff P. Mass spectrometric determination of o-glycosylation sites using beta-elimination and partial acid hydrolysis. Anal. Chem. 2001, 7361263–1269. [DOI] [PubMed] [Google Scholar]
- Hong J. C.; Kim Y. S. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: A novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections. Glycoconjugate J. 2000, 1710691–703. [DOI] [PubMed] [Google Scholar]
- Gerken T. A.; Gupta R.; Jentoft N. A novel approach for chemically deglycosylating o-linked glycoproteins. The deglycosylation of submaxillary and respiratory mucins. Biochemistry 1992, 313639–648. [DOI] [PubMed] [Google Scholar]
- Edge A. S. Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: Elucidation of molecular structure and function. Biochem. J. 2003, 376Pt 2339–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang Y.; Mechref Y.; Novotny M. V. Microscale nonreductive release of o-linked glycans for subsequent analysis through maldi mass spectrometry and capillary electrophoresis. Anal. Chem. 2001, 73246063–6069. [DOI] [PubMed] [Google Scholar]
- Lazar I. M.; Lee W.; Lazar A. C. Glycoproteomics on the rise: Established methods, advanced techniques, sophisticated biological applications. Electrophoresis 2013, 341113–125. [DOI] [PubMed] [Google Scholar]
- Wuhrer M.; Catalina M. I.; Deelder A. M.; Hokke C. H. Glycoproteomics based on tandem mass spectrometry of glycopeptides. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 8491–2115–128. [DOI] [PubMed] [Google Scholar]
- Steentoft C.; Vakhrushev S. Y.; Vester-Christensen M. B.; Schjoldager K. T.; Kong Y.; Bennett E. P.; Mandel U.; Wandall H.; Levery S. B.; Clausen H. Mining the o-glycoproteome using zinc-finger nuclease-glycoengineered simplecell lines. Nat. Methods 2011, 811977–982. [DOI] [PubMed] [Google Scholar]
- Wollscheid B.; Bausch-Fluck D.; Henderson C.; O’Brien R.; Bibel M.; Schiess R.; Aebersold R.; Watts J. D. Mass-spectrometric identification and relative quantification of n-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 274378–386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang H.; Aebersold R. Isolation of glycoproteins and identification of their n-linked glycosylation sites. Methods Mol. Biol. 2006, 328, 177–185. [DOI] [PubMed] [Google Scholar]
- Sun B.; Ranish J. A.; Utleg A. G.; White J. T.; Yan X.; Lin B.; Hood L. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol. Cell. Proteomics 2007, 61141–149. [DOI] [PubMed] [Google Scholar]
- Zhou Y.; Aebersold R.; Zhang H. Isolation of n-linked glycopeptides from plasma. Anal. Chem. 2007, 79155826–5837. [DOI] [PubMed] [Google Scholar]
- Berven F. S.; Ahmad R.; Clauser K. R.; Carr S. A. Optimizing performance of glycopeptide capture for plasma proteomics. J. Proteome Res. 2010, 941706–1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun B.; Utleg A. G.; Hu Z.; Qin S.; Keller A.; Lorang C.; Gray L.; Brightman A.; Lee D.; Alexander V.; Ranish J.; Moritz R. L.; Hood L. Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteome. J. Proteome Res. 2013, 12, 2034–2044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tian Y.; Zhou Y.; Elliott S.; Aebersold R.; Zhang H. Solid-phase extraction of n-linked glycopeptides. Nat. Protoc. 2007, 22334–339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramachandran P.; Boontheung P.; Pang E.; Yan W.; Wong D. T.; Loo J. A. Comparison of n-linked glycoproteins in human whole saliva, parotid, submandibular, and sublingual glandular secretions identified using hydrazide chemistry and mass spectrometry. Clin. Proteomics 2008, 43–480–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen R.; Jiang X.; Sun D.; Han G.; Wang F.; Ye M.; Wang L.; Zou H. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 2009, 82651–661. [DOI] [PubMed] [Google Scholar]
- Sparbier K.; Koch S.; Kessler I.; Wenzel T.; Kostrzewa M. Selective isolation of glycoproteins and glycopeptides for maldi-tof ms detection supported by magnetic particles. J. Biomol. Tech. 2005, 164407–413. [PMC free article] [PubMed] [Google Scholar]
- Zou Z.; Ibisate M.; Zhou Y.; Aebersold R.; Xia Y.; Zhang H. Synthesis and evaluation of superparamagnetic silica particles for extraction of glycopeptides in the microtiter plate format. Anal. Chem. 2008, 8041228–1234. [DOI] [PubMed] [Google Scholar]
- Chen J.; Shah P.; Zhang H. Solid phase extraction of n-linked glycopeptides using hydrazide tip. Anal. Chem. 2013, 852210670–10674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gonzalez J.; Takao T.; Hori H.; Besada V.; Rodriguez R.; Padron G.; Shimonishi Y. A method for determination of n-glycosylation sites in glycoproteins by collision-induced dissociation analysis in fast atom bombardment mass spectrometry: Identification of the positions of carbohydrate-linked asparagine in recombinant alpha-amylase by treatment with peptide-n-glycosidase f in 18o-labeled water. Anal. Biochem. 1992, 2051151–158. [DOI] [PubMed] [Google Scholar]
- Kuster B.; Mann M. 18o-labeling of n-glycosylation sites to improve the identification of gel-separated glycoproteins using peptide mass mapping and database searching. Anal. Chem. 1999, 7171431–1440. [DOI] [PubMed] [Google Scholar]
- Kaji H.; Saito H.; Yamauchi Y.; Shinkawa T.; Taoka M.; Hirabayashi J.; Kasai K.; Takahashi N.; Isobe T. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify n-linked glycoproteins. Nat. Biotechnol. 2003, 216667–672. [DOI] [PubMed] [Google Scholar]
- Shakey Q.; Bates B.; Wu J. An approach to quantifying n-linked glycoproteins by enzyme-catalyzed 18o3-labeling of solid-phase enriched glycopeptides. Anal. Chem. 2010, 82187722–7728. [DOI] [PubMed] [Google Scholar]
- Liu Z.; Cao J.; He Y.; Qiao L.; Xu C.; Lu H.; Yang P. Tandem 18o stable isotope labeling for quantification of n-glycoproteome. J. Proteome Res. 2010, 91227–236. [DOI] [PubMed] [Google Scholar]
- Hagglund P.; Matthiesen R.; Elortza F.; Hojrup P.; Roepstorff P.; Jensen O. N.; Bunkenborg J. An enzymatic deglycosylation scheme enabling identification of core fucosylated n-glycans and o-glycosylation site mapping of human plasma proteins. J. Proteome Res. 2007, 683021–3031. [DOI] [PubMed] [Google Scholar]
- Hagglund P.; Bunkenborg J.; Elortza F.; Jensen O. N.; Roepstorff P. A new strategy for identification of n-glycosylated proteins and unambiguous assignment of their glycosylation sites using hilic enrichment and partial deglycosylation. J. Proteome Res. 2004, 33556–566. [DOI] [PubMed] [Google Scholar]
- Zhang W.; Wang H.; Zhang L.; Yao J.; Yang P. Large-scale assignment of n-glycosylation sites using complementary enzymatic deglycosylation. Talanta 2011, 851499–505. [DOI] [PubMed] [Google Scholar]
- Zielinska D. F.; Gnad F.; Wisniewski J. R.; Mann M. Precision mapping of an in vivo n-glycoproteome reveals rigid topological and sequence constraints. Cell 2010, 1415897–907. [DOI] [PubMed] [Google Scholar]
- Zhu J.; Wang F.; Cheng K.; Dong J.; Sun D.; Chen R.; Wang L.; Ye M.; Zou H. A simple integrated system for rapid analysis of sialic-acid-containing n-glycopeptides from human serum. Proteomics 2013, 1381306–1313. [DOI] [PubMed] [Google Scholar]
- Zhou H.; Hou W.; Denis N. J.; Vasilescu J.; Zou H.; Figeys D. Glycoproteomic reactor for human plasma. J. Proteome Res. 2009, 82556–566. [DOI] [PubMed] [Google Scholar]
- Lam M. P.; Lau E.; Siu S. O.; Ng D. C.; Kong R. P.; Chiu P. C.; Yeung W. S.; Lo C.; Chu I. K. Online combination of reversed-phase/reversed-phase and porous graphitic carbon liquid chromatography for multicomponent separation of proteomics and glycoproteomics samples. Electrophoresis 2011, 32212930–2940. [DOI] [PubMed] [Google Scholar]
- Zhu J.; Wang F.; Chen R.; Cheng K.; Xu B.; Guo Z.; Liang X.; Ye M.; Zou H. Centrifugation assisted microreactor enables facile integration of trypsin digestion, hydrophilic interaction chromatography enrichment, and on-column deglycosylation for rapid and sensitive n-glycoproteome analysis. Anal. Chem. 2012, 84115146–5153. [DOI] [PubMed] [Google Scholar]
- Hofmann A.; Gerrits B.; Schmidt A.; Bock T.; Bausch-Fluck D.; Aebersold R.; Wollscheid B. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells. Blood 2010, 11613e26–e34. [DOI] [PubMed] [Google Scholar]
- Nagano K.; Shinkawa T.; Kato K.; Inomata N.; Yabuki N.; Haramura M. Distinct cell surface proteome profiling by biotin labeling and glycoprotein capturing. J. Proteomics 2011, 74101985–1993. [DOI] [PubMed] [Google Scholar]
- Schiess R.; Mueller L. N.; Schmidt A.; Mueller M.; Wollscheid B.; Aebersold R. Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry. Mol. Cell. Proteomics 2009, 84624–638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adamczyk B.; Tharmalingam T.; Rudd P. M. Glycans as cancer biomarkers. Biochim. Biophys. Acta 2012, 182091347–1353. [DOI] [PubMed] [Google Scholar]
- Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl. Acad. Sci. U. S. A. 2002, 991610231–10233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim E. H.; Misek D. E. Glycoproteomics-based identification of cancer biomarkers. Int. J. Proteomics 2011, 2011, 601937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Narimatsu H.; Sawaki H.; Kuno A.; Kaji H.; Ito H.; Ikehara Y. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010, 277195–105. [DOI] [PubMed] [Google Scholar]
- Tian Y.; Zhang H. Glycoproteomics and clinical applications. Proteomics Clin. Appl. 2010, 42124–132. [DOI] [PubMed] [Google Scholar]
- Tian Y.; Kelly-Spratt K. S.; Kemp C. J.; Zhang H. Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues. J. Proteome Res. 2010, 9115837–5847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zielinska D. F.; Gnad F.; Schropp K.; Wisniewski J. R.; Mann M. Mapping n-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol. Cell 2012, 464542–548. [DOI] [PubMed] [Google Scholar]
- Almen M. S.; Nordstrom K. J.; Fredriksson R.; Schioth H. B. Mapping the human membrane proteome: A majority of the human membrane proteins can be classified according to function and evolutionary origin. BMC Biol. 2009, 7, 50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babu M.; Vlasblom J.; Pu S.; Guo X.; Graham C.; Bean B. D.; Burston H. E.; Vizeacoumar F. J.; Snider J.; Phanse S.; Fong V.; Tam Y. Y.; Davey M.; Hnatshak O.; Bajaj N.; Chandran S.; Punna T.; Christopolous C.; Wong V.; Yu A.; Zhong G.; Li J.; Stagljar I.; Conibear E.; Wodak S. J.; Emili A.; Greenblatt J. F. Interaction landscape of membrane-protein complexes in saccharomyces cerevisiae. Nature 2012, 4897417585–589. [DOI] [PubMed] [Google Scholar]
- Sun Z.; Chen R.; Cheng K.; Liu H.; Qin H.; Ye M.; Zou H. A new method for quantitative analysis of cell surface glycoproteome. Proteomics 2012, 12223328–3337. [DOI] [PubMed] [Google Scholar]
- Palmisano G.; Melo-Braga M. N.; Engholm-Keller K.; Parker B. L.; Larsen M. R. Chemical deamidation: A common pitfall in large-scale n-linked glycoproteomic mass spectrometry-based analyses. J. Proteome Res. 2012, 1131949–1957. [DOI] [PubMed] [Google Scholar]
- Bantscheff M.; Lemeer S.; Savitski M. M.; Kuster B. Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Anal. Bioanal. Chem. 2012, 4044939–965. [DOI] [PubMed] [Google Scholar]
- Bantscheff M.; Schirle M.; Sweetman G.; Rick J.; Kuster B. Quantitative mass spectrometry in proteomics: A critical review. Anal Bioanal. Chem. 2007, 38941017–1031. [DOI] [PubMed] [Google Scholar]
- Becker C. H.; Bern M. Recent developments in quantitative proteomics. Mutat. Res. 2011, 7222171–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elliott M. H.; Smith D. S.; Parker C. E.; Borchers C. Current trends in quantitative proteomics. J. Mass Spectrom. 2009, 44121637–1660. [DOI] [PubMed] [Google Scholar]
- Panchaud A.; Affolter M.; Moreillon P.; Kussmann M. Experimental and computational approaches to quantitative proteomics: Status quo and outlook. J. Proteomics 2008, 71119–33. [DOI] [PubMed] [Google Scholar]
- Rodriguez-Suarez E.; Whetton A. D. The application of quantification techniques in proteomics for biomedical research. Mass Spectrom Rev. 2013, 3211–26. [DOI] [PubMed] [Google Scholar]
- Kim Y. J.; Zaidi-Ainouch Z.; Gallien S.; Domon B. Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring. Nat. Protoc 2012, 75859–871. [DOI] [PubMed] [Google Scholar]
- McDonald C. A.; Yang J. Y.; Marathe V.; Yen T. Y.; Macher B. A. Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome. Mol. Cell. Proteomics 2009, 82287–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
